|Last Price||Today's Change||52-Week Range||Trading Volume|
|63.98||-0.53 (-0.82%)||52.06 - 71.60||7.3 million (Below Avg)|
Market data as of 4:04PM 08/28/15. Quotes are delayed by at least 15 min.
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
07/27/2015 7:00 AM ET